Crosstalk between oral squamous cell carcinoma cells and cancer-associated fibroblasts via the TGF-β/SOX9 axis in cancer progression.
3D in vitro model
CAFs
Oral squamous cell carcinoma
SOX9
TGF-β
Journal
Translational oncology
ISSN: 1936-5233
Titre abrégé: Transl Oncol
Pays: United States
ID NLM: 101472619
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
14
07
2021
revised:
07
09
2021
accepted:
01
10
2021
pubmed:
9
10
2021
medline:
9
10
2021
entrez:
8
10
2021
Statut:
ppublish
Résumé
Cancer-associated fibroblasts (CAFs) have important roles in promoting cancer development and progression. We previously reported that high expression of sex-determining region Y (SRY)-box9 (SOX9) in oral squamous cell carcinoma (OSCC) cells was positively correlated with poor prognosis. This study developed three-dimensional (3D) in vitro models co-cultured with OSCC cells and CAFs to examine CAF-mediated cancer migration and invasion in vitro and in vivo. Moreover, we performed an immunohistochemical analysis of alpha-smooth muscle actin and SOX9 expression in surgical specimens from 65 OSCC patients. The results indicated that CAFs promote cancer migration and invasion in migration assays and 3D in vitro models. The invading OSCC cells exhibited significant SOX9 expression and changes in the expression of epithelial-mesenchymal transition (EMT) markers, suggesting that SOX9 promotes EMT. TGF-β1 signalling inhibition reduced SOX9 expression and cancer invasion in vitro and in vivo, indicating that TGF-β1-mediated invasion is dependent on SOX9. In surgical specimens, the presence of CAFs was correlated with SOX9 expression in the invasive cancer nests and had a significant impact on regional recurrence. These findings demonstrate that CAFs promote cancer migration and invasion via the TGF-β/SOX9 axis.
Identifiants
pubmed: 34624685
pii: S1936-5233(21)00228-X
doi: 10.1016/j.tranon.2021.101236
pmc: PMC8502776
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101236Informations de copyright
Copyright © 2021. Published by Elsevier Inc.